Related Experiment Videos
Early vitrectomy for progressive diabetic proliferations covering the macula
The British Journal of Ophthalmology
|June 1, 1994
Summary
Pars plana vitrectomy effectively treats diabetic fibrovascular proliferations in the macula. This surgical approach preserves socially useful vision for many patients with advanced diabetic retinopathy.
Area of Science:
- Ophthalmology
- Retinal Surgery
- Diabetic Retinopathy Management
Background:
- Diabetic fibrovascular proliferations can cause significant visual impairment.
- Progression despite photocoagulation and cryoablation necessitates alternative treatments.
- Macular involvement by fibrovascular tissue without detachment is a specific clinical scenario.
Purpose of the Study:
- To analyze the clinical outcomes of pars plana vitrectomy for diabetic fibrovascular proliferations.
- To evaluate the efficacy of this surgical intervention in preserving visual acuity.
- To assess the rate of reproliferation after surgery.
Main Methods:
- Retrospective analysis of 50 eyes undergoing pars plana vitrectomy.
- Inclusion criteria: progressive fibrovascular proliferations despite prior treatments, macular coverage, no macular detachment.
- Follow-up ranged from 13 to 39 months (mean 24 months).
Main Results:
- 72% of eyes showed improved visual acuity 12 months postoperatively.
- 64% achieved a final visual acuity of 0.2 or better.
- 90% gained at least 0.05 in visual acuity, with only 2 eyes experiencing reproliferation.
Conclusions:
- Pars plana vitrectomy is a viable surgical option for diabetic fibrovascular proliferations involving the macula.
- The procedure can preserve or improve visual acuity in a majority of treated eyes.
- It offers a favorable outcome in preventing further visual loss due to macular fibrovascularization.